123 related articles for article (PubMed ID: 20973110)
1. Variations in labeling protocol influence incorporation, distribution and retention of iron oxide nanoparticles into human umbilical vein endothelial cells.
van Tiel ST; Wielopolski PA; Houston GC; Krestin GP; Bernsen MR
Contrast Media Mol Imaging; 2010; 5(5):247-57. PubMed ID: 20973110
[TBL] [Abstract][Full Text] [Related]
2. In vitro labeling of endothelial progenitor cells isolated from peripheral blood with superparamagnetic iron oxide nanoparticles.
Sun JH; Zhang YL; Nie CH; Qian SP; Yu XB; Xie HY; Zhou L; Zheng SS
Mol Med Rep; 2012 Aug; 6(2):282-6. PubMed ID: 22580964
[TBL] [Abstract][Full Text] [Related]
3. In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner.
Zhang Z; van den Bos EJ; Wielopolski PA; de Jong-Popijus M; Bernsen MR; Duncker DJ; Krestin GP
MAGMA; 2005 Sep; 18(4):175-85. PubMed ID: 16096808
[TBL] [Abstract][Full Text] [Related]
4. Intracellular labeling of mouse embryonic stem cell-derived neural progenitor aggregates with micron-sized particles of iron oxide.
Sart S; Bejarano FC; Baird MA; Yan Y; Rosenberg JT; Ma T; Grant SC; Li Y
Cytotherapy; 2015 Jan; 17(1):98-111. PubMed ID: 25527864
[TBL] [Abstract][Full Text] [Related]
5. Effects of iron oxide nanoparticle labeling on human endothelial cells.
Yang FY; Yu MX; Zhou Q; Chen WL; Gao P; Huang Z
Cell Transplant; 2012; 21(9):1805-20. PubMed ID: 22776829
[TBL] [Abstract][Full Text] [Related]
6. Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study.
Boutry S; Brunin S; Mahieu I; Laurent S; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2008; 3(6):223-32. PubMed ID: 19072771
[TBL] [Abstract][Full Text] [Related]
7. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
Ittrich H; Lange C; Dahnke H; Zander AR; Adam G; Nolte-Ernsting C
Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549
[TBL] [Abstract][Full Text] [Related]
8. Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes.
Puppi J; Mitry RR; Modo M; Dhawan A; Raja K; Hughes RD
Cell Transplant; 2011; 20(6):963-75. PubMed ID: 21092412
[TBL] [Abstract][Full Text] [Related]
9. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency.
Matuszewski L; Persigehl T; Wall A; Schwindt W; Tombach B; Fobker M; Poremba C; Ebert W; Heindel W; Bremer C
Radiology; 2005 Apr; 235(1):155-61. PubMed ID: 15749976
[TBL] [Abstract][Full Text] [Related]
10. Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticles.
Jiang J; Chen Y; Zhu Y; Yao X; Qi J
Cancer Biother Radiopharm; 2011 Aug; 26(4):461-7. PubMed ID: 21812654
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance signal detection of superparamagnetic iron oxide nanoparticles and its biological effects on endothelial cells].
Tan YB; Wu XY; Zhang JF; Zhang MM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 39(2):118-24. PubMed ID: 20387237
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging.
Schlorf T; Meincke M; Kossel E; Glüer CC; Jansen O; Mentlein R
Int J Mol Sci; 2010 Dec; 12(1):12-23. PubMed ID: 21339973
[TBL] [Abstract][Full Text] [Related]
13. Cell quantification: evolution of compartmentalization and distribution of iron-oxide particles and labeled cells.
Kotek G; van Tiel ST; Wielopolski PA; Houston GC; Krestin GP; Bernsen MR
Contrast Media Mol Imaging; 2012; 7(2):195-203. PubMed ID: 22434632
[TBL] [Abstract][Full Text] [Related]
14. Labelling of olfactory ensheathing cells with micron-sized particles of iron oxide and detection by MRI.
Sandvig I; Hoang L; Sardella TC; Barnett SC; Brekken C; Tvedt K; Berry M; Haraldseth O; Sandvig A; Thuen M
Contrast Media Mol Imaging; 2012; 7(4):403-10. PubMed ID: 22649046
[TBL] [Abstract][Full Text] [Related]
15. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function.
Oude Engberink RD; van der Pol SM; Döpp EA; de Vries HE; Blezer EL
Radiology; 2007 May; 243(2):467-74. PubMed ID: 17456871
[TBL] [Abstract][Full Text] [Related]
16. Design of iron oxide nanoparticles with different sizes and surface charges for simple and efficient labeling of mesenchymal stem cells.
Jo J; Aoki I; Tabata Y
J Control Release; 2010 Mar; 142(3):465-73. PubMed ID: 19932720
[TBL] [Abstract][Full Text] [Related]
17. Labeling of multiple cell lines using a new iron oxide agent for cell tracking by MRI.
McFadden C; Mallett CL; Foster PJ
Contrast Media Mol Imaging; 2011; 6(6):514-22. PubMed ID: 22144030
[TBL] [Abstract][Full Text] [Related]
18. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
19. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.
Zhang B; Jiang B; Chen Y; Huang H; Xie Q; Kang M; Zhang H; Zhai C; Wu Y
Contrast Media Mol Imaging; 2012; 7(1):35-44. PubMed ID: 22344878
[TBL] [Abstract][Full Text] [Related]
20. Somatic differentiation and MR imaging of magnetically labeled human embryonic stem cells.
Nejadnik H; Henning TD; Castaneda RT; Boddington S; Taubert S; Jha P; Tavri S; Golovko D; Ackerman L; Meier R; Daldrup-Link HE
Cell Transplant; 2012; 21(12):2555-67. PubMed ID: 22862886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
